CD8A and breast cancer: To assess this in the context of BC, we employed single-cell RNA sequencing of patient CD8+ T cells from 10 patients with BC, including 9 primary tumors, 2 T+ LNs, 3 NCBTs, and 7 matched PBMC samples (Supplemental Figure 4).